Neuland Laboratories shares gain on USFDA nod for BMS Schizophrenia Drug

Neuland Laboratories Share Price | Analysts believe that the stock’s sharp upward movement reflects investor optimism about Neuland’s potential role in the production of this promising new therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *